By South Asia Monitor/JEN | @justearthnews | 16 Jun 2021, 08:29 am Print
Johnson and Johnson Image: Wikimedia Commons
Bangladesh has approved Johnson and Johnson’s single-dose Covid-19 for emergency use in the country, making it the sixth vaccine to get approval. The country is all set to resume its national vaccination campaign on Saturday.
On Tuesday, the country’s Directorate-General of Drug Administration (DGDA) has granted emergency use approval to the vaccine after scrutinized all document and clinal trial data submitted by the manufacturer, reported Dhaka Tribune.
So far, it has approved six vaccines for usage in the country: AstraZeneca-Oxford vaccine, Sputnik-V, Pfizer, Sinopharm, and Sinovac. However, Astra-Zeneca and Sinopharm are the two main vaccines used for the national vaccination drive.
The supply of the Astra-Zeneca/Covishield vaccine was disrupted in April this year following the disastrous Covid-19 surge in India, prompting the Indian government to halt the export.
- WHO and partners activate Global Health Emergency Corps for the first time over mpox outbreak
- Latest WHO report shows TB has replaced COVID-19 as leading infectious disease killer in 2023
- New UNICEF report says 85 per cent of children affected by polio in 2023 lived in fragile, conflict-affected areas
- Hajj pilgrimage: WHO announces collaboration with Saudi Arabia on health card initiative
- Egypt is now 44th malaria-free country in the world, certifies WHO
